Successful azacitidine based treatment of therapy related myelodysplastic syndrome with normal karyotype occurred after acute myeloid leukemia

被引:0
|
作者
Saltarelli, F. [1 ]
Tatarelli, C. [1 ]
Spiriti, M. A. Aloe [1 ]
Naso, V. [1 ]
Bianchi, M. P. [1 ]
Bianchi, M. P. [1 ]
Conte, E. [1 ]
Proia, S. [1 ]
Ferrari, A. [1 ]
机构
[1] Univ Roma La Sapienza, S Andrea Hosp, Hematol, I-00185 Rome, Italy
关键词
D O I
10.1016/S0145-2126(13)70241-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-194
引用
收藏
页码:S110 / S111
页数:2
相关论文
共 50 条
  • [21] DECITABINE AS THERAPY FOR A PATIENT WITH ACUTE MYELOID LEUKEMIA SECONDARY TO MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE: A CASE REPORT
    Guaragna, G.
    Rinaldi, E.
    Spina, A.
    Mele, G.
    Quarta, G.
    Melpignano, A.
    HAEMATOLOGICA, 2017, 102 : 159 - 159
  • [22] Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
    Litzow, Mark R.
    Tarima, Sergey
    Perez, Waleska S.
    Bolwell, Brian J.
    Cairo, Mitchell S.
    Camitta, Bruce M.
    Cutler, Corey S.
    de Lima, Marcos
    DiPersio, John F.
    Gale, Robert Peter
    Keating, Armand
    Lazarus, Hillard M.
    Luger, Selina
    Marks, David I.
    Maziarz, Richard T.
    McCarthy, Philip L.
    Pasquini, Marcelo C.
    Phillips, Gordon L.
    Rizzo, J. Douglas
    Sierra, Jorge
    Tallman, Martin S.
    Weisdorf, Daniel J.
    BLOOD, 2010, 115 (09) : 1850 - 1857
  • [23] Azathioprine: Association with Therapy-related Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Kwong, Yok-Lam
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 485 - 490
  • [24] Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome
    Chua, Chong Chyn
    Fleming, Shaun
    Wei, Andrew H.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (01) : 3 - 12
  • [25] Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype
    Samra, Bachar
    Richard-Carpentier, Guillaume
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    DiNardo, Courtney D.
    Issa, Ghayas C.
    Bose, Prithviraj
    Konopleva, Marina Y.
    Yilmaz, Musa
    Ohanian, Maro
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Pierce, Sherry
    Cortes, Jorge E.
    Kantarjian, Hagop
    Short, Nicholas J.
    BLOOD CANCER JOURNAL, 2020, 10 (05)
  • [26] Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype
    Bachar Samra
    Guillaume Richard-Carpentier
    Tapan M. Kadia
    Farhad Ravandi
    Naval Daver
    Courtney D. DiNardo
    Ghayas C. Issa
    Prithviraj Bose
    Marina Y. Konopleva
    Musa Yilmaz
    Maro Ohanian
    Gautam Borthakur
    Guillermo Garcia-Manero
    Sherry Pierce
    Jorge E. Cortes
    Hagop Kantarjian
    Nicholas J. Short
    Blood Cancer Journal, 10
  • [27] A Case of Therapy-Related Acute Myeloid Leukemia With a Normal Karyotype After Sustained Molecular Complete Remission of Acute Promyelocytic Leukemia
    Park, Sang Hyuk
    Chi, Hyun-Sook
    Cho, Young-Uk
    Jang, Seongsoo
    Park, Chan-Jeoung
    Lee, Je-Hwan
    ANNALS OF LABORATORY MEDICINE, 2014, 34 (01) : 68 - 70
  • [28] Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)
    Bally, Cecile
    Thepot, Sylvain
    Quesnel, Bruno
    Vey, Norbert
    Dreyfus, Francois
    Fadlallah, Jehane
    Turlure, Pascal
    de Botton, Stephane
    Dartigeas, Caroline
    de Renzis, Benoit
    Itzykson, Raphael
    Fenaux, Pierre
    Ades, Lionel
    LEUKEMIA RESEARCH, 2013, 37 (06) : 637 - 640
  • [29] Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
    Helbig, Grzegorz
    Chromik, Karolina
    Wozniczka, Krzysztof
    Kopinska, Anna J.
    Boral, Kinga
    Dworaczek, Martyna
    Koclega, Anna
    Armatys, Anna
    Panz-Klapuch, Marta
    Markiewicz, Miroslaw
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (03) : 1175 - 1180
  • [30] SAFETY PROFILE OF AZACITIDINE IN THE TREATMENT OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKAEMIA
    Minoia, C.
    Sgherza, N.
    Greco, G.
    Buquicchio, C.
    Loseto, G.
    de Fazio, V.
    Iacobazzi, A.
    Rana, A.
    Merchionne, F.
    Tarantini, G.
    Pavone, V.
    Guarini, A.
    HAEMATOLOGICA, 2014, 99 : 619 - 619